STRO - Sutro Biopharma Chief Business Officer Sold $72K In Company Stock | Benzinga
Brunilda Shtylla, Chief Business Officer at Sutro Biopharma (NASDAQ:STRO), reported a large insider sell on August 29, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Shtylla sold 15,428 shares of Sutro Biopharma. The total transaction amounted to $72,594.
Sutro Biopharma shares are trading down 0.63% at $4.75 at the time of this writing on Wednesday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
The Importance of Insider Transactions
Insider transactions shouldn't be used primarily to ...